Under policy changes, chain drugstore giants are expected to undertake sustained high performance

In recent years, with the advancement of policies such as prescription outflows, public hospital reforms, medical insurance control fees, volume purchases, and "dual channels", the pharmaceutical retail industry has undergone tremendous changes, and the industry concentration has continued to increase.
Large chain pharmacies rely on capital Forces continue to build and merge, and further chain expansion, while small and medium pharmacies are either eliminated or merged.
On the whole, the chain rate of retail pharmacies is rising
.
From the perspective of the industry, under policy changes, pharmacy giants are expected to continue high performance, and revenue and profit growth will remain above 20% within 3 to 5 years
.
Compared with individual pharmacies, the chain pharmacy giant has many years of high-standard store construction and operation experience, and has a complete management system, strict quality control and a drug storage and logistics system, and has a strong ability to undertake prescription outflows
.
Judging from the undertaking capacity of the four major chain pharmacies that have received much attention, it can be said to be on par
.
Among them, Dashenlin focuses on building a chronic disease health management brand in the industry, including the establishment of chronic disease service points based on the advantages of the business district, the establishment of chronic disease posts, file management, follow-up visits, assessment mechanisms and a series of system processes, using online and offline Integrated professional services have increased store frequency and customer stickiness.
At present, Dashenlin has trained 1,200 chronic disease professionals and nearly 1,200 chronic disease stores
.
There are more than 10,000 licensed pharmacists and pharmacists .
At present, the integrated development of diversified businesses of Dashenlin has entered a stage of accelerated growth
.
Yixintang vigorously develops the pharmacy business and hospital-side store business for special chronic diseases
.
Among them, in the pharmacy business for special chronic diseases, Yixintang has increased its investment in chronic disease business, focusing on building customers' drug purchase experience and customer health needs
.
As of the end of the half-year report period, Yixintang had opened 814 chronic disease medical insurance stores, and chronic disease medical insurance stores accounted for 10.
11% of the total number of stores in the group
.
The hospital-side store business is a retail pharmacy that can quickly take over the outflow of prescriptions in the future.
Yixintang's expansion of newly-added hospital-side stores in the first half of the year is progressing steadily.
As of the end of the half-year reporting period, the number of hospital-side stores of Yixintang Grade II and above hospitals reached 583.

.
Facing policies such as the gradual liberalization of online sales of prescription drugs, tiered diagnosis and treatment, unified medical insurance payment, and dual-channel policies, the common people actively responded, and on this basis, vigorously developed the chronic disease business, and made multiple plans to undertake the prescription efflux bonus
.
For example, in response to the gradual liberalization of online sales of prescription drugs, ordinary people will take advantage of offline store layout, actively develop online business, and continue to deploy O2O and B2C businesses
.
In order to strengthen the management of chronic diseases and the construction of pharmaceutical services, during the reporting period, the common people have trained 4,875 chronic disease managers, and set up self-test Bluetooth for chronic diseases such as blood sugar, blood pressure, heart rate, blood uric acid, and blood lipids in 4,647 stores across the country.
Smart device
.
Yifeng pharmacy through actively carry out cooperation with the health insurance sector insurance companies, medical institutions, and pharmaceutical manufacturers, health insurance payments, to undertake the functions of community health, hospital prescribing information sharing, prescription transfer and other online and offline active exploration
.
At the same time, Yifeng Pharmacy also promoted in-depth strategic cooperation with prescription drug manufacturers by accelerating the construction of hospital-side stores and DTP/DTC professional pharmacies
.
In addition, it is also committed to improving the management of professional pharmacy services for chronic diseases and prescription drugs.
For example, for chronic disease and prescription drug customers, the establishment of chronic disease counters, special areas, specialty stores, and chronic disease management specialists
.